Symbiomix Therapeutics, LLC

États‑Unis d’Amérique

 
Quantité totale PI 3
Rang # Quantité totale PI 509 586
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 679 757

Brevets

Marques

0 0
0 0
3 0
0
 
Dernier brevet 2019 - Novel secnidazole soft gelatin c...
Premier brevet 2015 - Secnidazole for use in the treat...

Derniers inventions, produits et services

2018 Invention Novel secnidazole soft gelatin capsule formulations and uses thereof. Embodiments described herei...
2016 Invention Novel nitroimidazole formulations and uses thereof. Embodiments described herein are directed to ...
2015 Invention Secnidazole for use in the treatment of bacterial vaginosis. Embodiments are directed to a secnid...